TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Sulforaphene, Carboplatin
Phytochemical Name Sulforaphene (PubChem CID: 6433206 )
Anticancer drug Name Carboplatin (PubChem CID: 426756 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 573
Pair Name Sulforaphene, Carboplatin
Disease Info [ICD-11: 2C25] Lung cancer Investigative
Biological Phenomena Induction-->Apoptosis
Gene Regulation Up-regulation Expression BAX hsa581
Down-regulation Expression BCL2 hsa596
Up-regulation Expression CASP3 hsa836
Up-regulation Expression CASP9 hsa842
Up-regulation Expression CYCS hsa54205
Down-regulation Expression JUN hsa3725
Down-regulation Phosphorylation MAPK1 hsa5594
Down-regulation Phosphorylation MAPK3 hsa5595
Up-regulation Cleavage PARP1 hsa142
Down-regulation Expression PIK3CA hsa5290
In Vitro Model A-549 Lung adenocarcinoma Homo sapiens (Human) CVCL_0023
Result This study demonstrates that the duel character of this combination therapy may be an effective replacement for conventional therapy alone against NSCLC.
03. Reference
No. Title Href
1 Sulforaphene-Carboplatin Combination Synergistically Enhances Apoptosis by Disruption of Mitochondrial Membrane Potential and Cell Cycle Arrest in Human Non-Small Cell Lung Carcinoma. J Med Food. 2016 Sep;19(9):860-9. doi: 10.1089/jmf.2016.3675. Click
It has been 46620 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP